Data Query
IBB
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net Asset Value: | Change: | Change: |
USD 174.19 | USD -1.41 | -0.81% |
| Price | Change: | Change: |
USD 174.19 | USD -1.48 | -0.85% |
The investment seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology Index (the "underlying index"). The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index contains securities of NASDAQ® listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by The NASDAQ OMX Group, Inc. The fund is non-diversified.
Holdings
| Top 10 Holdings | |
| Regeneron Pharmaceuticals, Inc. | 9.97% |
| Gilead Sciences Inc | 8.44% |
| Amgen Inc | 6.94% |
| Celgene Corporation | 6.63% |
| Biogen Idec Inc | 6.35% |
| Alexion Pharmaceuticals, Inc. | 5.84% |
| Vertex Pharmaceuticals | 4.90% |
| Perrigo Company | 3.13% |
| Biomarin Pharmaceutical, Inc. | 3.11% |
| Onyx Pharmaceuticals, Inc. | 2.77% |
| Weighting | 58.09% |
| As of 05/31/2013 | |
Holdings - Country Allocation |
Download Adobe Flash Player to view this page
| Holdings - Sector Breakdowns |
Download Adobe Flash Player to view this page
Historical NAV Performance (%)
1-Day | 1-Week | 1-Mo | 3-Mo | YTD | 1-Yr |
-0.81 | -2.32 | 4.17 | 21.46 | 30.81 | 46.35 |
| Cumulative | |||||
2012 | 2011 | 2010 | 2009 | 3 Yr* | 5 Yr* |
32.13 | 11.72 | 14.83 | 15.17 | 30.72 | 18 |
| Annual/Annualized | |||||
Portfolio & Management
| Fundamentals | |
| Mean Market Cap: | 10,881.63 |
| P/E Ratio: | 27.28 |
| P/B Ratio: | 6.17 |
| Dividend Yield (% p.a): | 0.35 |
| Sharpe Ratio 3Yr: | 1.79 |
| r-Squared (3 Yr): | 50.78 |
| Std Dev 3 Year: | 15.77 |
| Alpha: | 18.33 |
| Beta: | 0.72 |
| Dividend Frequency: | Quarterly |
| Portfolio Characteristics | |
| Assets Under Management: | 3,148,164,601 |
| Exp Ratio: | 0.48 |
| Number of Holdings: | 126 |
| Management | |
| Issuing Company: | iShares |
| Inc Date: | 2001-02-05 |
| Trading Symbols: | IBB |
| Trading & Liquidity | |
| Spread: | 0.084 |
| % Spread: | 0.0005 |
| Average Daily Dollar Volume: | 111,419,307 |
| Average Daily Share Volume: | 635,161 |
Related Articles
| Related Articles | |
The content on IndexUniverse.com and related sites is for informational purposes only. It is not designed to be used by investors in making specific investment decisions. The content is not intended as advice or recommendation.
© 2013 Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.
